Drake & Associates’s Columbia Research Enhanced Core ETF RECS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.2M Buy
1,252,310
+92,006
+8% +$3.9M 9.13% 1
2026
Q1
$45.2M Buy
1,160,304
+153,902
+15% +$6.24M 8.62% 2
2025
Q4
$41.1M Buy
1,006,402
+80,366
+9% +$3.27M 8.19% 2
2025
Q3
$37.6M Buy
926,036
+85,763
+10% +$3.31M 7.88% 2
2025
Q2
$30.9M Buy
840,273
+35,148
+4% +$1.19M 7.57% 2
2025
Q1
$26.7M Buy
805,125
+16,521
+2% +$575K 7.51% 2
2024
Q4
$28M Buy
+788,604
New +$27.7M 7.96% 2

Other funds holding RECS

Drake & Associates's RECS Position: Q2 2026 in Review

Drake & Associates increased its Columbia Research Enhanced Core ETF (RECS) stake by 7.9% in Q2 2026, buying an estimated $3.9M and bringing the position to 1,252,310 shares worth $54.2M. The position accounts for 9.13% of the portfolio, ranked #1.

Drake & Associates first reported a position in RECS in Q4 2024 and has held it in 7 quarters since. 185 funds tracked by Wall St. Rank hold RECS as of Q2 2026.

  • Drake & Associates held 1,252,310 shares of Columbia Research Enhanced Core ETF worth $54.2M as of Q2 2026.
  • Drake & Associates bought 92,006 Columbia Research Enhanced Core ETF shares in Q2 2026, an estimated $3.9M.
  • Columbia Research Enhanced Core ETF made up 9.13% of Drake & Associates's portfolio in Q2 2026, its #1 holding.
  • Drake & Associates first reported a position in Columbia Research Enhanced Core ETF in Q4 2024 and has held it in 7 quarters since.
  • 185 funds tracked by Wall St. Rank held Columbia Research Enhanced Core ETF as of Q2 2026.

Based on Drake & Associates's 13F filing for Q2 2026, filed 10 Aug 2026.